{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:37:51Z","timestamp":1785181071461,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93842-4","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T03:31:20Z","timestamp":1742527880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and validation of a machine learning-based nomogram for predicting prognosis in lung cancer patients with malignant pleural effusion"],"prefix":"10.1038","volume":"15","author":[{"given":"Xin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiluo","family":"Heibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"issue":"140","key":"93842_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","volume":"25","author":"I Psallidas","year":"2016","unstructured":"Psallidas, I., Kalomenidis, I., Porcel, J. M., Robinson, B. W. & Stathopoulos, G. T. Malignant pleural effusion: From bench to bedside. Eur. Respir. Rev. 25 (140), 189\u2013198 (2016).","journal-title":"EUR. RESPIR REV."},{"key":"93842_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/CMAR.S95663","volume":"9","author":"E Penz","year":"2017","unstructured":"Penz, E., Watt, K. N., Hergott, C. A., Rahman, N. M. & Psallidas, I. Management of malignant pleural effusion: Challenges and solutions. Cancer Manag. Res. 9, 229\u2013241 (2017).","journal-title":"CANCER MANAG RES."},{"issue":"18","key":"93842_CR3","first-page":"1754","volume":"378","author":"D Feller-Kopman","year":"2018","unstructured":"Feller-Kopman, D. & Light, R. Pleural disease. New. Engl. J. Med. 378 (18), 1754 (2018).","journal-title":"NEW. ENGL. J. MED."},{"key":"93842_CR4","doi-asserted-by":"crossref","unstructured":"Clive, A. O. et al. Predicting survival in malignant pleural effusion: Development and validation of the LENT prognostic score. Thorax 69(12), 1098\u20131104 (2014).","DOI":"10.1136\/thoraxjnl-2014-205285"},{"issue":"1","key":"93842_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccm.2017.11.004","volume":"39","author":"R Asciak","year":"2018","unstructured":"Asciak, R. & Rahman, N. M. Malignant pleural effusion: From diagnostics to therapeutics. Clin. Chest Med. 39 (1), 181\u2013193 (2018).","journal-title":"CLIN. CHEST MED."},{"issue":"1","key":"93842_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ejcts\/ezy258","volume":"55","author":"AC Bibby","year":"2019","unstructured":"Bibby, A. C. et al. ERS\/EACTS statement on the management of malignant pleural effusions. Eur. J. Cardio-Thorac. 55 (1), 116\u2013132 (2019).","journal-title":"EUR. J. CARDIO-THORAC"},{"key":"93842_CR7","doi-asserted-by":"crossref","first-page":"106802","DOI":"10.1016\/j.rmed.2022.106802","volume":"196","author":"SI Bashour","year":"2022","unstructured":"Bashour, S. I., Mankidy, B. J. & Lazarus, D. R. Update on the diagnosis and management of malignant pleural effusions. Resp. Med. 196, 106802 (2022).","journal-title":"RESP. MED."},{"key":"93842_CR8","doi-asserted-by":"crossref","first-page":"694129","DOI":"10.3389\/fphar.2021.694129","volume":"12","author":"G Zhu","year":"2021","unstructured":"Zhu, G. et al. Evaluation of efficacy and safety for Kanglaite injection in the control of the malignant pleural effusions via thoracic perfusion: A systematic review and Meta-Analysis of randomized controlled trials. Front. Pharmacol. 12, 694129 (2021).","journal-title":"FRONT. PHARMACOL."},{"issue":"3","key":"93842_CR9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/qjmed\/hct245","volume":"107","author":"AM Egan","year":"2014","unstructured":"Egan, A. M., McPhillips, D., Sarkar, S. & Breen, D. P. Malignant pleural effusion. QJM-Int J. MED. 107 (3), 179\u2013184 (2014).","journal-title":"QJM-INT J. MED."},{"issue":"7","key":"93842_CR10","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.21037\/jtd.2018.04.160","volume":"10","author":"M Chalhoub","year":"2018","unstructured":"Chalhoub, M., Saqib, A. & Castellano, M. Indwelling pleural catheters: Complications and management strategies. J. Thorac. Dis. 10 (7), 4659\u20134666 (2018).","journal-title":"J. THORAC. DIS."},{"issue":"5 Suppl","key":"93842_CR11","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.12-2377","volume":"143","author":"FC Detterbeck","year":"2013","unstructured":"DetterbeckFC, LewisSZ, Diekemper, R., Addrizzo-Harris, D. & Alberts, W. M. Executive summary: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143 (5 Suppl), 7S\u201337S (2013).","journal-title":"CHEST"},{"issue":"11","key":"93842_CR12","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/eji.202048548","volume":"50","author":"J Ma","year":"2020","unstructured":"Ma, J., Zhang, H., Tang, K. & Huang, B. Tumor-derived microparticles in tumor immunology and immunotherapy. Eur. J. Immunol. 50 (11), 1653\u20131662 (2020).","journal-title":"EUR. J. IMMUNOL."},{"issue":"9","key":"93842_CR13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1158\/2326-6066.CIR-19-0789","volume":"8","author":"P Xu","year":"2020","unstructured":"Xu, P. et al. Chemotherapeutic tumor microparticles elicit a neutrophil response targeting malignant pleural effusions. Cancer Immunol. Res. 8 (9), 1193\u20131205 (2020).","journal-title":"CANCER IMMUNOL. RES."},{"key":"93842_CR14","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.2147\/IJN.S281890","volume":"15","author":"J Shao","year":"2020","unstructured":"Shao, J., Zaro, J. & Shen, Y. Advances in exosome-based drug delivery and tumor targeting: From tissue distribution to intracellular fate. Int. J. Nanomed. 15, 9355\u20139371 (2020).","journal-title":"INT. J. NANOMED."},{"issue":"1","key":"93842_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12935-024-03211-w","volume":"24","author":"S Ge","year":"2024","unstructured":"Ge, S. et al. Immune modulation in malignant pleural effusion: From microenvironment to therapeutic implications. Cancer Cell. Int. 24 (1), 105 (2024).","journal-title":"CANCER CELL. INT."},{"issue":"5","key":"93842_CR16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/1568009618666171129145703","volume":"18","author":"L Alessandrini","year":"2018","unstructured":"Alessandrini, L. et al. Cancer targeted therapy strategy: The pathologist\u2019s perspectives. Curr. Cancer Drug Tar. 18 (5), 410\u2013420 (2018).","journal-title":"CURR. CANCER DRUG TAR"},{"issue":"148","key":"93842_CR17","first-page":"167","volume":"27","author":"S Jonna","year":"2019","unstructured":"Jonna, S. & Subramaniam, D. S. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): An update. Discov. Med. 27 (148), 167\u2013170 (2019).","journal-title":"DISCOV MED."},{"issue":"12","key":"93842_CR18","first-page":"1803","volume":"129","author":"M Herrera-Juarez","year":"2023","unstructured":"Herrera-Juarez, M., Serrano-Gomez, C., Bote-de-Cabo, H. & Paz-Ares, L. Targeted therapy for lung cancer: Beyond EGFR and ALK. Cancer-Am. Cancer Soc. 129 (12), 1803\u20131820 (2023).","journal-title":"CANCER-AM CANCER SOC."},{"issue":"1","key":"93842_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-022-02287-3","volume":"20","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z. & Li, M. Targeted therapies for cancer. BMC Med. 20 (1), 90 (2022).","journal-title":"BMC MED."},{"issue":"1","key":"93842_CR20","doi-asserted-by":"crossref","first-page":"20220575","DOI":"10.1515\/biol-2022-0575","volume":"18","author":"L Yang","year":"2023","unstructured":"Yang, L. & Wang, Y. Malignant pleural effusion diagnosis and therapy. Open. Life Sci. 18 (1), 20220575 (2023).","journal-title":"OPEN. LIFE SCI."},{"issue":"3","key":"93842_CR21","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.athoracsur.2018.04.073","volume":"106","author":"G Karpathiou","year":"2018","unstructured":"Karpathiou, G. et al. Peoc\u2019H M: pericardial and pleural metastases: Clinical, histologic, and molecular differences. Ann. Thorac. Surg. 106 (3), 872\u2013879 (2018).","journal-title":"ANN. THORAC. SURG."},{"issue":"11","key":"93842_CR22","first-page":"1147","volume":"70","author":"CA Pawlak","year":"2012","unstructured":"Pawlak, C. A. et al. Diagnosis of malignant pericarditis: A single centre experience. Kardiol Pol. 70 (11), 1147\u20131153 (2012).","journal-title":"KARDIOL POL."},{"issue":"4","key":"93842_CR23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccl.2017.07.005","volume":"35","author":"A Azarbal","year":"2017","unstructured":"Azarbal, A. & LeWinter, M. M. Pericardial effusion. Cardiol. Clin. 35 (4), 515\u2013524 (2017).","journal-title":"CARDIOL. CLIN."},{"issue":"1","key":"93842_CR24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-023-00446-1","volume":"9","author":"Y Adler","year":"2023","unstructured":"Adler, Y. et al. Cardiac tamponade. Nat. Rev. Dis. Primers. 9 (1), 36 (2023).","journal-title":"NAT. REV. DIS. PRIMERS"},{"key":"93842_CR25","doi-asserted-by":"crossref","first-page":"961440","DOI":"10.3389\/fonc.2022.961440","volume":"12","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Current status of and progress in the treatment of malignant pleural effusion of lung cancer. Front. Oncol. 12, 961440 (2022).","journal-title":"FRONT. ONCOL."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93842-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93842-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93842-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T03:31:44Z","timestamp":1742527904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93842-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93842"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93842-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Medical Ethics Committee of Affiliated Hospital of North Sichuan Medical College with file number 2023ER423-1. Informed consent was waived due to the retrospective nature of the study, where data was sourced from the hospital\u2019s electronic medical records and electronic health check databases.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"9714"}}